Jean Elwing, MD

Professor of medicine and director of the Pulmonary Hypertension Program at University of Cincinnati Health

Articles by Jean Elwing, MD

Ralinepag's Benefit Spans Broad PAH Population, With Jean Elwing, MD

October 23rd 2026

Jean Elwing, MD, discusses what drove ralinepag's reduction in PAH clinical worsening in ADVANCE Outcomes and where the it could fit if approved.

Ralinepag Cuts PAH Worsening in Low-Risk Patients, With Jean Elwing, MD

ByJean Elwing, MD

October 23rd 2026

Jean Elwing, MD, discusses a CHEST 2026 subgroup analysis showing ralinepag reduces clinical worsening in PAH even among patients with low-risk criteria.

Jean Elwing, MD

Articles by Jean Elwing, MD

Ralinepag's Benefit Spans Broad PAH Population, With Jean Elwing, MD

Ralinepag Cuts PAH Worsening in Low-Risk Patients, With Jean Elwing, MD

Latest Updated Articles

Trending on HCPLive

Retatrutide Lowers Albuminuria, Glomerular Pressure in Obesity and CKD

Sleeve Gastrectomy Improves Heart, Kidney MRI Markers in Youth-Onset T2D

TELIGAN: Telitacicept Preserves eGFR Through 2 Years in IgA Nephropathy

Ravulizumab Receives FDA Accelerated Approval for IgA Nephropathy

Edoxaban Fails to Improve Stroke Risk, Increases Bleeding Risk After Intracranial Hemorrhage